Motion Sickness on Astrolabe's Vessel

Sea Sickness Clinical Trial

— SICKVEST  

Official title:

Evaluation and Characterization of Motion Sickness on Passengers Sailing on the Astrolabe

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02911402
• Other study ID #: 14-153
• Status: Completed
• Start date: October 2014
• Est. completion date: December 2018

Study information

• Verified date: January 2022
• Source: University Hospital, Caen
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Sea sickness syndrome is present for 80% of persons on board when the boat rotation missions Astrolabe, sometimes there is a risk of very significant dehydration. A special unit specialized in the fundamental study of the vestibular system (inner ear), sensory organ at the base of visual-vestibular conflict inducing this syndrome, also provides medical support for parabolic flights (flight reproducing weightlessness) where this syndrome is strongly present. The goal of the study is to assess the frequency of occurrence of this sea sickness syndrome on the Astrolabe, to understand the triggers (type of boat movements, personality traits, anxiety / stress) without changing habits on board for those on board taking a antinaupathique treatment given by the ship's doctor. This study will be done in collaboration between INSERM U 1075 (France) and the Laboratory of military research VIPER specialized in extreme environments (Belgium). The ultimate goal will be to provide the best recommendations and the best treatment regimen to alleviate as best as possible the symptoms of people on board of the Astrolabe so scientists on board can perform their work.

Description:

Background: The objectives were to assess the prevalence, severity, medication taken and to look for predictive factors, in order to better identify characteristics of passengers at risk of motion sickness during transport scientists travelling from Hobart in Tasmania to the French polar stations in Antarctica. Methods: Two hundred and thirty-nine passengers were surveyed over 4 years with 4 round trips per year using Motion Sickness Susceptibility Questionnaire (MSSQ), Simulator Sickness Questionnaire (SSQ), state-trait anxiety test (STAI-Trait and STAI-State), and general parameters (age, gender, number of trips, jet-lag, direction of the trip), medication, calculation of the distance of each passenger's cabin to the Centre of Gravity (CoG.).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 147
• Est. completion date: December 2018
• Est. primary completion date: December 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• participant aged of 18 or older but younger than 70 who received their medical ability to travel to Terre Adélie or making a research cruise aboard the Astrolabe
• particpant signing the informed consent.

Exclusion Criteria:

• none

Related Conditions & MeSH terms

• Motion Sickness
• Sea Sickness

Intervention

Other:
• sea sickness questionnaires

Locations

Country	Name	City	State
France	Caen University Hospital	Caen

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Caen

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Motion Sickness susceptibilty questionnaire (fMSSQ)	Sensitivity of motion sickness	day 1 to day 10
Primary	STAY-YA questionnaire	anxiety	day 1 to day 10
Primary	STAY-YB questionnaire	anxiety	day 1 to day 10
Primary	Vis-Morgen Questonnaire about sleeping	Subjective sleep scoring	day 1 to day 10
Primary	Fatigue questionnaire	Tiredness	day 1 to day 10
Primary	Dietary intake survey	food intake	day 1 to day 10
Secondary	type of movement from the ship using use the data from the Dynamic Positioning System on board	boat motion	baseline and every day up to 10 days
Secondary	data from individual actigraphs worn by the participants	this will allow to quantify particpant's movements related to the ship movement	baseline and every day up to 10 days
Secondary	personnality questionnaire (OCEAN)	Personnality	baseline and every day up to 10 days
Secondary	anxiety questionnaire (STAY).	anxiety	baseline and every day up to 10 days
Secondary	treatment taken (international denomination and dose)	treatment taken by subject for motion sickness	baseline and every day up to 6 days